Leslie  Shaw  to  Enzyme-Linked Immunosorbent Assay
                            
                            
                                This is a "connection" page, showing publications  Leslie  Shaw  has written about  Enzyme-Linked Immunosorbent Assay.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.283
         
        
        
     
 
    
        
        - 
            Shaw LM, Hansson O, Manuilova E, Masters CL, Doecke JD, Li QX, Rutz S, Widmann M, Leinenbach A, Blennow K. Method comparison study of the Elecsys? ?-Amyloid (1-42) CSF assay versus comparator assays and LC-MS/MS. Clin Biochem. 2019 Oct; 72:7-14.
            
            
                Score: 0.144
            
         
        
        - 
            Shaw LM. Mycophenolate mofetil: pharmacokinetic strategies for optimizing immunosuppression. Drug Metabol Drug Interact. 1997; 14(1):33-40.
            
            
                Score: 0.031
            
         
        
        - 
            Pannee J, Gobom J, Shaw LM, Korecka M, Chambers EE, Lame M, Jenkins R, Mylott W, Carrillo MC, Zegers I, Zetterberg H, Blennow K, Portelius E. Round robin test on quantification of amyloid-? 1-42 in cerebrospinal fluid by mass spectrometry. Alzheimers Dement. 2016 Jan; 12(1):55-9.
            
            
                Score: 0.028
            
         
        
        - 
            Ramakers IH, Verhey FR, Scheltens P, Hampel H, Soininen H, Aalten P, Rikkert MO, Verbeek MM, Spiru L, Blennow K, Trojanowski JQ, Shaw LM, Visser PJ. Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment. Psychol Med. 2013 May; 43(5):911-20.
            
            
                Score: 0.023
            
         
        
        - 
            Fagan AM, Shaw LM, Xiong C, Vanderstichele H, Mintun MA, Trojanowski JQ, Coart E, Morris JC, Holtzman DM. Comparison of analytical platforms for cerebrospinal fluid measures of ?-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology. Arch Neurol. 2011 Sep; 68(9):1137-44.
            
            
                Score: 0.021
            
         
        
        - 
            Venkataramanan R, Shaw LM, Sarkozi L, Mullins R, Pirsch J, MacFarlane G, Scheller D, Ersfeld D, Frick M, Fitzsimmons WE, Virji M, Jain A, Brayman KL, Shaked A. Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients. J Clin Pharmacol. 2001 May; 41(5):542-51.
            
            
                Score: 0.010
            
         
        
        - 
            MacFarlane GD, Shaw LM, Venkataramanan R, Mullins R, Scheller DG, Ersfeld DL. Analysis of whole blood tacrolimus concentrations in liver transplant patients exhibiting impaired liver function. Ther Drug Monit. 1999 Dec; 21(6):585-92.
            
            
                Score: 0.009
            
         
        
        - 
            MacFarlane GD, Scheller DG, Ersfeld DL, Shaw LM, Venkatarmanan R, Sarkozi L, Mullins R, Fox BR. Analytical validation of the PRO-Trac II ELISA for the determination of tacrolimus (FK506) in whole blood. Clin Chem. 1999 Sep; 45(9):1449-58.
            
            
                Score: 0.009
            
         
        
        - 
            Salm P, Taylor PJ, Clark A, Balderson GA, Grygotis A, Norris RL, Lynch SV, Shaw LM, Pond SM. High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants. Ther Drug Monit. 1997 Dec; 19(6):694-700.
            
            
                Score: 0.008